Benzylpiperazine derivatives useful for the treatment of gastrointestinal disorders
申请人:Glaxo Group Limited
公开号:EP2441763A1
公开(公告)日:2012-04-18
The present invention relates to novel benzylpiperazine derivatives such as compounds of formula (I), which have activity as agonists of the GPR38 receptor
and the use of such compounds or pharmaceutical compositions thereof in the treatment of gastrointestinal disorders.